Introducing Evosep Proteomics to Standardize and Scale Proteomics for Research and Drug DevelopmentSAN DIEGO, June 01, 2026 (GLOBE NEWSWIRE) -- Evosep announces the launch of Evosep Proteomics, an ecosystem designed to standardize and scale LC-MS–based proteomics for research and pharmaceutical drug development.
Evosep Launches IQ/OQ Protocols for the Evosep Eno System at WCBP 2026Washington, D.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- WCBP -- Evosep is proud to announce a major advancement in quality assurance for pharmaceutical and regulated laboratories with the introduction of Installation Qualification (IQ) and Operational Qualification (OQ) protocols for its Evosep Eno system. This milestone will be showcased at the WCBP Symposium in Washington, reinforcing Evosep’s commitment to enable seamless integration of high-throughput proteomics into environments where precision, reliability, and compliance are paramount.
Evosep Unveils Open Innovation Initiative to Expand Standardization in ProteomicsTORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- HUPO World Congress – Evosep, a global leader in proteomics solutions, is proud to announce a new initiative at HUPO 2025 aimed at solving one of LCMS based proteomics most persistent challenges: sample preparation. Building on its legacy of standardizing proteomics LC separation, Evosep is now expanding upstream to deliver robust, and reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics.
Evosep Joins P4ML to Power World’s Largest Multi-Omic Human Health Study of Two Million SamplesSAINT-MALO, France, June 17, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML - OMIC-Assist Study—the world’s largest multi-omic precision medicine initiative, launched by P4ML alongside its strategic academic, health regulatory, and semi-state partners in the United Arab Emirates.
Evosep unveils new instrumentation and partnership at ASMS 2025BALTIMORE, Md., June 02, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in proteomics solutions, is proud to announce the launch of the Evosep Eno™, a robust, high-throughput separation tool preparing for next generation workflow integration for LC-MS based proteomics. This new platform will significantly enhance the company’s ability to advance the use of LC-MS based proteomics as a vital tool for the pharmaceutical and biotech industries. In addition, Evosep has entered into a reseller agreement with SCIEX to support pharmaceutical companies in analyzing a broader range of drug modalities more efficiently and at greater scale.
